Wockhardt Surges 4% on New Drug Approval Buzz

Wockhardt shares surged as much as 4 per cent to hit intraday high of Rs 1,453.05 on Monday after reports suggested that the company got approval for a new analgesic drug from US Food & Drug Administration (USFDA).
  As per the media reports Wockhardt's new analgesic drug Oxycodone Hydrochloride has got approval from the USFDA. The new drug approval will add to company's revenues going ahead, analysts said.


Wockhardt shares ended 2.6 per cent higher at Rs 1,435.80 apiece, outperforming the broader Nifty, which ended 1.56 per cent higher.